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Melanoma originated from melanocytes is the most aggressive type of skin cancer.
Despite considerable progresses in clinical treatment with the discovery of BRAF or
MEK inhibitors and monoclonal antibodies, the durability of response to treatment is
often limited to the development of acquired resistance and systemic toxicity. The
limited success of conventional treatment highlights the importance of understanding
the role of melanoma tumor microenvironment in tumor developement and drug
resistance. Nanoparticles represent a promising strategy for the development of new
cancer treatments able to improve the bioavailability of drugs and increase their
penetration by targeting specifically tumors cells and/or tumor environment. In this
review, we will discuss the main influence of tumor microenvironment in melanoma
growth and treatment outcome. Furthermore, third generation loaded
nanotechnologies represent an exciting tool for detection, treatment, and escape from
possible mechanism of resistance mediated by tumor microenvironment, and will be
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